Proliferating lymphocytes

Proliferating lymphocytes represent a dynamic cellular state where T and B cells undergo rapid clonal expansion in response to antigenic stimulation (NIH, 2023). This process is essential for a functional adaptive immune response but becomes a pathological driver in autoimmune diseases, transplant rejection, and lymphoid malignancies (NCBI, 2022). While not a single molecular target, this cell population is the functional focus of various immunosuppressive and antineoplastic therapies. These drugs often exploit the metabolic vulnerabilities of dividing cells, such as their heavy reliance on de novo nucleotide synthesis pathways (StatPearls, 2023). For example, mycophenolate mofetil specifically targets inosine monophosphate dehydrogenase (IMPDH) to arrest the proliferation of these cells. Monitoring the proliferative index of lymphocytes using markers like Ki-67 is a standard practice in pathology to assess the aggressiveness of lymphomas and the efficacy of treatment (Wikipedia, 2024).

Other names

Activated lymphocytesDividing T and B cellsLymphoblastsMitogen-stimulated lymphocytes

Inhibition of de novo purine or pyrimidine biosynthesis, disruption of DNA replication, blockade of IL-2 signaling via mTOR inhibition, or calcineurin inhibition to prevent cell cycle entry.